CNBX · CNBX Pharmaceuticals Inc.
$0.00
+0.00 (+0.00%)
At close · Jul 21
Going-concern doubt
— flagged Jun 24, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While the Company has incurred a net loss of $311,982 for the nine months ended May 31, 2026, it has incurred cumulative losses since inception of $25,580,358. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.”View the 10-Q filed Jun 24, 2026
Market Cap
$160,576
Shares
1.61B
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$313.98K
+54.8%
FY2025
Gross Margin
100%
0pp
FY2017
Operating Margin
-448.31%
-221.2pp
FY2024
Diluted EPS
$0.00
+100%
FY2025
Operating Cash Flow
-$171.31K
+29.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $130.07K | $410.17K | $29.96K | $0 | $7157 | $9843 | $9601 | $5684 | $112.5K | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | -$39.81K | -$16.8K | — | — | — | — | -$18.35K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $5684 | $112.5K | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | 100% | 100% | — | — | — | — | — | — | — | — | — | — | — | |
| $0 | $0 | $194.79K | $431.57K | $1.18M | $1.77M | $1.68M | $1.54M | $1M | $246.94K | $177.61K | $139.44K | $0 | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $20.25K | $60K | $288.16K | $422.02K | $287.46K | $960 | $62.72K | $0 | — | — | — | — | — | — | — | — | — | |
| $429.46K | $271.69K | $518.43K | $909.98K | $1.8M | $828.64K | $1.31M | $1.48M | $2.39M | $1.33M | $214.61K | $334.35K | $40.44K | $100 | $45 | $11.13K | $2180 | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $2153 | $2153 | $2153 | — | — | — | — | — | — | |
| $429.46K | $271.69K | $713.21K | $1.34M | $2.98M | $2.6M | $3.05M | $3.31M | $3.82M | $1.86M | $393.18K | $536.5K | $216.13K | $58.11K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $502.75K | $1652 | $144.41K | $111.17K | — | — | — | — | — | |
| -$429.46K | -$271.69K | -$583.14K | -$931.38K | -$2.95M | -$2.6M | -$3.04M | -$3.3M | -$3.81M | -$1.85M | -$280.68K | -$536.5K | -$216.13K | -$58.11K | — | — | — | — | — | — | — | — | |
| — | — | -448.31% | -227.07% | -9860.37% | — | -42524.12% | -33563.01% | -39670.12% | -32616.1% | -249.49% | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -$55.96K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | $852 | $4373 | $7178 | $3026 | $971 | $179 | $1458 | $1458 | — | — | — | — | — | — | |
| $51.94K | $42.29K | $23.12K | $52.62K | $782.08K | $594.27K | -$4.42M | $4.44M | $32.11K | -$69.03K | -$27.89K | -$3026 | -$3009 | $1710 | — | — | — | — | — | — | — | — | |
| — | — | — | — | $0 | $0 | $105.88K | $142.23K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | -$541.39K | -$219.14K | -$56.4K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | — | — | — | — | — | — | — | — | |
| -$462.09K | -$313.98K | -$695.2K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $1.13M | -$3.78M | -$1.93M | -$307.18K | -$541.39K | -$270.01K | -$56.4K | -$1652 | -$107.31K | -$114.98K | -$114.92K | -$27.46K | -$23.2K | -$20.02K | -$1800 | |
| — | — | -534.46% | -904.57% | -12428.23% | — | -104337.91% | 11510.41% | -39335.66% | -34022.54% | -273.05% | — | — | — | — | — | — | — | — | — | — | — | |
| -$462.09K | -$313.98K | -$695.2K | -$3.71M | -$4.39M | -$2.33M | -$13.05M | $3.94M | -$3.78M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$0.02 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$0.02 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 90.65M | 30.25M | 8.82M | 1.22M | 138.52M | 1.12M | 1.1M | 1M | 919.84K | 860.49K | 839.22K | 430.27K | 11.34K | 5668.35 | 5668.35 | — | — | — | — | — | — |
| shares | — | 90.65M | 30.25M | 8.82M | 1.22M | 138.52M | 1.12M | 1.1M | 1M | 919.84K | 860.49K | 839.22K | 430.27K | 11.34K | 5668.35 | 5668.35 | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.68×
EV/EBIT
—
Biotechnology median 26.56×
P/E (TTM)
0.10×
Biotechnology median 7.21×